Iohexol
Iohexol is a pharmaceutical drug with 42 clinical trials. Currently 5 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
13
Early Stage
2
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
79.4%
27 of 34 finished
20.6%
7 ended early
5
trials recruiting
42
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy Subjects
A Study of LY3526318 in Healthy Male Japanese Participants
Fluorescent Probe for Assessment of Renal Elimination
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Clinical Trials (42)
A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy Subjects
A Study of LY3526318 in Healthy Male Japanese Participants
Fluorescent Probe for Assessment of Renal Elimination
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
A Study of LY4515100 in Healthy Participants
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
Low-acid Contrast Media for Preventing Post ERCP Pancreatitis
Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study
Virtual Colonoscopy Using Omnipaque as a Contrast Agent
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function
Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance
Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration Rate
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 42